Shandong Xinhua Pharmaceutical Company Limited (FRA:XIN)

Germany · Delayed Price · Currency is EUR

0.7250

-0.0100 (-1.36%)

Last updated: Feb 23, 2026, 8:12 AM CET

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Chemical Raw Materials	2.75B	3.15B	3.19B	2.76B	2.64B
Chemical Raw Materials Growth	-12.60%	-1.37%	15.71%	4.59%	10.05%
Pharmaceutical Intermediates and Other Products	2.55B	2.26B	2.11B	2.12B	1.51B
Pharmaceutical Intermediates and Other Products Growth	12.76%	7.01%	-0.13%	39.81%	9.13%
Preparations	5.21B	4.56B	3.99B	3.31B	3.31B
Preparations Growth	14.49%	14.23%	20.36%	-0.05%	4.36%
Offset	-2.05B	-1.86B	-1.79B	-1.63B	-1.46B
Total	8.47B	8.10B	7.50B	6.56B	6.01B
Total Growth	4.51%	7.97%	14.37%	9.23%	7.13%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China (Including Hong Kong)	6.33B	5.93B	-	-	3.91B
China (Including Hong Kong) Growth	6.72%	-	-	-	3.61%
Americas	921.44M	763.82M	-	-	821.70M
Americas Growth	20.63%	-	-	-	10.22%
Europe	798.42M	1.02B	-	-	892.42M
Europe Growth	-22.02%	-	-	-	41.06%
Others	414.25M	379.69M	-	-	381.27M
Others Growth	9.10%	-	-	-	-16.00%
Total	8.47B	8.10B	-	-	6.01B
Total Growth	4.51%	-	-	-	7.13%

Source: S&P Global Market Intelligence.